Karachi, Highnoon Laboratories Limited informed Pakistan Stock Exchange about the recommendations made by the board of directors in the meeting held at Lahore on October 22, 2021.
The agenda of the meeting was discussion of Unconsolidated and consolidated profit and loss account for quarter ended September 30, 2021 which portrayed a profit of Rs. 377,100,883 and Rs. 390,772,784 with earnings per share 9.90 and 10.26 basic and diluted respectively.
Further, nil payment of cash dividend, bonus shares and right shares was agreed.
Highnoon Laboratories Limited was incorporated in Pakistan. The Company is principally engaged in the manufacture, import, sale and marketing of pharmaceutical and allied consumer products.
The total numbers of shares are 38,076,441. The Earnings per share is 41.01 in 2020 which was 28.05 in 2019. The Profit after Taxation is 1,420,736,000 in 2020 which was 971,013,000 in 2019.